- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.03. | Stocks in focus: Zee Ent, Glenmark and more | 3 | Times of India | ||
| 16.03. | Stocks in focus: Glenmark, Orient Paper and more | 3 | Times of India | ||
| 13.03. | Which shares to buy? Maruti, Glenmark, ONGC and other stocks analysts recommend this week | 2 | ZEE Business | ||
| 13.03. | Buy, sell or hold strategy march 13 2023 share price today bse nse Tech Mahindra HAL Glenmark SAIL RBL Bank Axis Bank Bank of Baroda Godrej Properties Shipping Corp Lupin | 2 | ZEE Business | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 27.02. | Glenmark's biotech company Ichnos Sciences lays off 50 | 2 | Endpoints News | ||
| 14.02. | Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case | 3 | FiercePharma | ||
| 13.02. | Merck, Glenmark Must Face Antitrust Trial Over Drug Pricing | 5 | CPI | ||
| 13.02. | Stocks in focus: LIC, Laurus Labs, Glenmark, Thermax, TVS Motor, Adani Ports and more | 2 | Times of India | ||
| 10.02. | Glenmark Q3 Results: Net profit jumps 21% YoY to Rs 291 crore | 3 | Times of India | ||
| 10.02. | Glenmark Pharma's third-quarter profit beats on strong India sales | 2 | Reuters.com | ||
| 27.01. | USFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facility | 3 | ZEE Business | ||
| 17.01. | India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma | 2 | Times of India | ||
| 21.12.22 | Glenmark Pharmaceuticals rises 5% on launching first 3-drug FDC for type-2 diabetes in India | 1 | Times of India | ||
| 19.12.22 | Glenmark Pharma gets USFDA nod for generic drug | 1 | ZEE Business | ||
| 12.12.22 | Stocks in the news: Uniparts, Airtel, NTPC, Vodafone Idea, Marico and Glenmark | 6 | Times of India | ||
| 06.12.22 | Glenmark hit with warning letter over procedures, quality control issues at India manufacturing plant | 1 | Endpoints News | ||
| 30.11.22 | Buy Glenmark Pharmaceuticals, target price Rs 580: Nomura, India | 1 | Times of India | ||
| 24.11.22 | Sensex gains 145 pts, Nifty50 above 18,300; Tata Consumer gains 2%; Glenmark sheds 2% | 2 | Times of India | ||
| 24.11.22 | Stocks in focus: Glenmark, HG Infra, HEG and more | 2 | Times of India | ||
| 22.11.22 | Glenmark Pharma inks settlement pact with Pfizer for cancer drug | 6 | ZEE Business |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,678 | +1,29 % | SINOPHARM (01099): ANNOUNCEMENT PRINCIPAL FINANCIAL DATA OF CNMDC FOR THE YEAR ENDED 31 DECEMBER 2022 | ||
| CSPC PHARMA | 0,893 | -2,66 % | Verlustreicher Tag für CSPC Pharmaceutical Group-Aktionäre: Aktienkurs sinkt deutlich | Zu den großen Verlierern am Aktienmarkt zählt heute das Wertpapier der CSPC Pharmaceutical Group . Das Wertpapier verbilligt sich am Donnerstag deutlich. Mit einem Kurssturz von 9,01 Prozent gehört... ► Artikel lesen | |
| WUXI BIOLOGICS | 5,783 | -2,95 % | WUXI BIO Foresees 2023 Rev. to Grow 30% | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,533 | +2,14 % | Syneos Health, Inc.: Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab | MORRISVILLE, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with... ► Artikel lesen | |
| DR REDDYS | 50,000 | 0,00 % | Coya Therapeutics In Deal With Dr. Reddy's To License Proposed Biosimilar Abatacept For Coya 302 | NEW DELHI (dpa-AFX) - Coya Therapeutics, Inc. (COYA), a clinical-stage biotechnology company, announced Monday a worldwide agreement with Dr. Reddy's Laboratories Limited. (RDY).Under the deal... ► Artikel lesen | |
| GEDEON RICHTER | 18,910 | +1,29 % | Aktien Osteuropa Schluss: Verluste vor US-Zinsentscheidung | PRAG/BUDAPEST/WARSCHAU (dpa-AFX) - Die wichtigsten Börsen Osteuropas haben am Mittwoch vor der am Abend anstehenden Zinsentscheidung der US-Notenbank Fed nachgegeben. Die meisten Experten gehen inzwischen... ► Artikel lesen | |
| ASPEN PHARMACARE | 9,100 | 0,00 % | ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of section 122(3) of the Companies Act and paragraph 3.83(b) of the JSE Listings Requirements | ||
| LUYE PHARMA | 0,402 | +0,50 % | LUYE PHARMA (02186): NOTICE OF BOARD MEETING | ||
| SHANGHAI PHARMACEUTICALS | 1,700 | 0,00 % | SH PHARMA (02607): NOTICE OF BOARD MEETING | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,092 | 0,00 % | SIHUAN PHARM (00460): RISK MANAGEMENT COMMITTEE TERMS OF REFERENCE ADOPTED BY THE BOARD ON 13 DECEMBER 2015 AND AMENDED BY THE BOARD ON 24 MARCH 2023 | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC PHARM (01558): ANNOUNCEMENT POSITIVE PROFIT ALERT | ||
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 0,830 | -0,60 % | SHINEWAY PHARM (02877): ANNOUNCEMENT IN RELATION TO (1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (2) CESSATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR ... | ||
| KALBE FARMA | 0,118 | 0,00 % | Kalbe Farma to place USD 10 million investment in Progen: PT Kalbe Farma Tbk (KLBF), a pharmaceutical ... | ||
| HANSOH PHARMACEUTICAL | 1,560 | -0,64 % | Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen und Hansoh Pharma geben Lizenzvereinbarung für Antikörper bekannt | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", SEHK: 02315), ein auf die klinische Phase spezialisiertes Biotechnologieunternehmen mit Schwerpunkt auf der Entdeckung und Entwicklung... ► Artikel lesen | |
| CHINA TRADITIONAL CHINESE MEDICINE | 0,464 | 0,00 % | TRAD CHI MED (00570): DATE OF BOARD MEETING |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
